Welgene Biotech Co.,Ltd. (TPEX:6661)

Market Cap	433.45M -19.7%
Revenue (ttm)	365.75M +18.5%
Net Income	1.64M
EPS	0.07
Shares Out	23.30M
PE Ratio	265.74
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,008
Average Volume	11,596
Open	19.10
Previous Close	19.10
Day's Range	18.60 - 19.10
52-Week Range	16.80 - 24.05
Beta	0.34
RSI	42.55
Earnings Date	Mar 12, 2026

About Welgene Biotech

Welgene Biotech Co.,Ltd. engages in the trade of biotechnology-related instruments, reagents, and biotechnology testing services. The company offers research services, including generation, PacBio third generation sequencing; microarray, protein body analysis; nucleic acid extraction/QC, single cell experimental, and bioinformatics analysis services. It also provides reagents, medical consumables, and instruments, as well as software services. Welgene Biotech Co.,Ltd. was founded in 2003 and is based in Taipei City, Taiwan.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2003
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6661